Verition Fund Management »

Biomarin Pharmaceutical shares owned by Verition Fund Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $19M 20M 0.96
2022-03-31 $403k 400k 1.01
2021-12-31 $524k 500k 1.05

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Warner Bros Discovery Com Ser A (WBD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Electronic Arts (EA)
Ishares Tr Russell 2000 Etf (IWM)
Palantir Technologies Cl A (PLTR)
Micron Technology (MU)

View all positions for Verition Fund Management

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Lazard Asset Management
BlackRock
Man Group
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Millennium Management
Verition Fund Management
Oaktree Capital Management
Victory Capital Management
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Jpmorgan Chase & Co

View all funds holding Biomarin Pharmaceutical